Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

STN-DBS is a Risk Factor of Sialorrhea in Patients With Advanced Parkinson's Disease

NCT06090929 is registered in ClinicalTrials.gov with Qilu Hospital of Shandong University as lead sponsor.

NCT NCT06090929
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06090929 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
STN-DBS is a Risk Factor of Sialorrhea in Patients With Advanced Parkinson's Disease
Lead sponsor
Qilu Hospital of Shandong University
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2019
Completion date
June 1, 2023
Enrollment
234 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease